OptimizeRx (OPRX)
(Real Time Quote from BATS)
$8.38 USD
-0.45 (-5.10%)
Updated Aug 7, 2024 02:00 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Earnings News For OPRX
-
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy?
-
OptimizeRx Reports First Quarter 2024 Financial Results
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
-
OptimizeRx Reports Third Quarter 2023 Financial Results
-
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
OptimizeRx Reports Second Quarter 2023 Financial Results
-
OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates
-
OptimizeRx Reports First Quarter 2023 Financial Results
-
OptimizeRx Corp. (OPRX) Q4 Earnings Beat Estimates
-
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
-
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
-
OptimizeRx Corp. (OPRX) to Report Q4 Results: Wall Street Expects Earnings Growth
-
OptimizeRx Corp. (OPRX) Tops Q3 Earnings Estimates
-
OptimizeRx Reports Third Quarter 2022 Financial Results
-
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
-
OptimizeRx Corp. (OPRX) Misses Q2 Earnings and Revenue Estimates
-
OptimizeRx Corp. (OPRX) Reports Next Week: What to Know Ahead of the Release
-
OptimizeRx Corp. (OPRX) Reports Q1 Loss, Lags Revenue Estimates
-
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline
-
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
-
OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth
-
OptimizeRx Corp. (OPRX) Misses Q3 Earnings Estimates
-
OptimizeRx Corp. (OPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates